compounding-hrt-solution-for
Compounding HRT Solutions for Testosterone Replacement Therapy Men
Educational information about compounded hormone therapy considerations for testosterone replacement therapy, including discussion of commonly prescribed medications and clinical context.
Not medical advice. Speak with a healthcare professional before using any medication.
Reviewed by:
Updated Feb, 15
Not sure what’s worth trying?
At Voshell’s Pharmacy, we believe in honest guidance — not hype. Visit us in-store or reach out to speak with a pharmacist who knows you and your health.
Contact UsCompounding HRT Solutions for Testosterone Replacement Therapy Men
DISCLOSURE: Voshell’s Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.
This page provides educational information about testosterone replacement therapy and medications typically discussed in its management. Testosterone replacement therapy is a medically supervised treatment for conditions such as hypogonadism, in which the body does not produce sufficient testosterone; clinical evaluation, laboratory testing, and ongoing monitoring are required. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. Compounded preparations may contain similar active ingredients but differ from commercially available products in formulation, testing, and regulatory status; they are not reviewed or approved by FDA before dispensing and are not interchangeable with commercially available products. Clinical decisions about the management of testosterone deficiency should be made with a qualified clinician — often an endocrinologist or urologist for endocrine conditions.
According to the Endocrine Society Clinical Practice Guideline on testosterone therapy in men with hypogonadism, treatment goals include restoring serum testosterone to mid-normal reference range values, and clinicians select formulation and dose based on documented deficiency, symptom burden, patient preference, and monitoring parameters. Commercially available testosterone products — including topical gels, transdermal patches, and injectable preparations — are the primary regulated options evaluated for this indication. Compounded preparations may be considered by a prescribing clinician in specific circumstances, such as a documented sensitivity to an excipient in a commercially available product or a requirement for a strength not otherwise obtainable, based on their clinical judgment.
Important note: Testosterone therapy is FDA-approved only for specific medical conditions (such as documented hypogonadism due to disorders of the testes, pituitary, or hypothalamus). Per FDA-approved prescribing information, testosterone products carry warnings regarding cardiovascular events, polycythemia, prostate effects, and effects on fertility, and require prescriber supervision and monitoring. Compounded testosterone preparations are not reviewed by FDA for safety or effectiveness before dispensing.
Common symptoms of Testosterone Replacement Therapy
Learn about common signs of hormonal imbalance and how they may affect overall health and well-being.
Acne or oily skin
According to NIH MedlinePlus and the Endocrine Society Clinical Practice Guideline, in testosterone replacement therapy, acne and oily skin may present as increased sebum production from sebaceous glands, resulting in enlarged pores, comedones, and inflammatory papules or pustules on the face, chest, and back. These changes reflect androgen-driven stimulation of sebaceous gland activity and may appear within weeks of initiating therapy or following dose adjustments. According to the FDA-approved prescribing information for testosterone products, acne is a recognized adverse effect of androgen therapy. Patients experiencing persistent, worsening, or severe skin eruptions should seek evaluation from a qualified clinician; sudden or rapidly spreading skin changes may indicate a reaction requiring prompt medical attention.
Increased facial or body hair growth
According to NIH MedlinePlus and the Endocrine Society Clinical Practice Guideline, in testosterone replacement therapy, increased facial or body hair growth may present as gradual development of coarse, dark hairs in androgen-sensitive areas — including the upper lip, chin, sideburns, chest, abdomen, back, and inner thighs. This change reflects androgenic effects on hair follicles and may intensify over weeks to months, sometimes accompanied by increased skin oiliness. According to the FDA-approved prescribing information for testosterone products, hirsutism is a recognized adverse effect associated with androgen therapy. Patients who experience unexpectedly rapid or extensive hair growth should seek evaluation from a qualified clinician, as this may indicate supratherapeutic androgen levels requiring dose review.
Scalp hair thinning
According to NIH MedlinePlus and the Endocrine Society Clinical Practice Guideline, in testosterone replacement therapy, scalp hair thinning may present as increased shedding and progressive follicle miniaturization, with hairs becoming finer, shorter, and less pigmented. Changes may begin at the temples and vertex and may progress gradually over months to years, reflecting androgenic effects on genetically susceptible hair follicles. According to the FDA-approved prescribing information for testosterone products, male-pattern baldness is listed among potential effects associated with androgen use. Patients noticing significant or accelerating hair loss should seek evaluation from a qualified clinician; sudden diffuse hair loss may indicate a separate underlying condition requiring assessment.
Mood changes
According to NIH MedlinePlus and the Endocrine Society Clinical Practice Guideline, in testosterone replacement therapy, mood changes may present as shifts in emotional state, including increased irritability, restlessness, emotional reactivity, reduced patience, or intermittent anxiety. Some individuals may also experience concentration difficulties or sleep disruption that accompanies these fluctuating emotional states. According to the FDA-approved prescribing information for testosterone products, mood-related effects including increased aggression and emotional lability are recognized adverse effects of androgen therapy. Patients experiencing significant or distressing mood changes should seek evaluation from a qualified clinician; abrupt or severe psychiatric symptoms may indicate supratherapeutic hormone levels or an unrelated condition requiring prompt attention.
Contact Us for a Personalized Care Plan
Have questions about compounding? Contact Voshell's Pharmacy — we prepare patient-specific medications pursuant to valid prescriptions from your licensed prescriber.
Compounded Hormone Therapy — Educational Information for Testosterone Replacement Therapy
Compounded Hormone Therapy Considerations in Testosterone Replacement Therapy — Educational Information
Testosterone replacement therapy requires diagnosis and ongoing clinical management by a qualified clinician — typically an endocrinologist or urologist. According to the Endocrine Society Clinical Practice Guideline on testosterone therapy in men with hypogonadism, the diagnosis should be confirmed by unambiguous clinical signs and symptoms of testosterone deficiency combined with consistently low morning serum testosterone concentrations measured on at least two occasions. Treatment selection, dosing, and monitoring are clinical decisions that belong with the prescribing clinician based on the individual’s documented deficiency, comorbidities, and therapeutic goals.
According to the FDA-approved prescribing information for AndroGel, Testim, Depo-Testosterone, and Androderm, commercially available testosterone formulations are indicated for replacement therapy in males with primary hypogonadism or hypogonadotropic hypogonadism. The Endocrine Society Clinical Practice Guideline describes that treatment aims to restore serum testosterone to mid-normal reference range concentrations, with ongoing monitoring of hematocrit, prostate-specific antigen, bone mineral density (where indicated), and clinical response. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared only in response to a valid individual prescription. Compounded preparations may contain similar active ingredients but differ from commercially available products in formulation, testing, and regulatory status. Compounded testosterone formulations may be considered by the prescribing clinician in specific clinical circumstances — for example, a documented hypersensitivity to an excipient in a commercially available product or a clinical need for a strength not otherwise available — based entirely on the clinician’s judgment.
FDA Boxed Warning — Testosterone Products: According to the FDA-approved prescribing information for testosterone products, the labeling carries warnings regarding the following: (1) secondary exposure risk — virilization of children and women may occur following direct skin contact with testosterone gel application sites; (2) cardiovascular risk — some studies have reported increased rates of cardiovascular adverse events in patients receiving testosterone therapy; (3) polycythemia — testosterone therapy may cause dose-dependent increases in hematocrit that may require dose reduction or discontinuation; (4) effects on fertility — testosterone therapy may reduce sperm production; (5) prostate effects — testosterone may stimulate growth of existing prostate tissue, and appropriate screening is required before and during therapy.
Patients and clinicians considering any testosterone preparation — commercially available or compounded — should review the full risk information in the prescribing clinician’s assessment and in the applicable labeling. This page is for educational purposes only and does not constitute medical advice, a treatment recommendation, or a claim regarding the safety or effectiveness of any compounded preparation.
Prescription Medications Discussed in Testosterone Replacement Therapy
Individualized compounded HRT therapies aimed at promoting hormonal stability and comprehensive health support.
AndroGel
According to the FDA-approved prescribing information for AndroGel, AndroGel is a topical testosterone gel indicated for testosterone replacement therapy in adult males with conditions associated with a deficiency or absence of endogenous testosterone, including primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired). The labeling describes that AndroGel delivers testosterone transdermally through an alcohol-based vehicle, producing gradual increases in serum testosterone concentrations and avoiding first-pass hepatic metabolism. Per the labeling, testosterone supplementation may be associated with cardiovascular adverse events, polycythemia, sleep apnea, changes in lipid profiles, and suppression of spermatogenesis; periodic monitoring of hematocrit, prostate-specific antigen, and serum testosterone is described as required. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing. Commercially available AndroGel is a separately regulated product, and clinical decisions regarding therapy belong with the prescribing clinician.
Testim
According to the FDA-approved prescribing information for Testim, Testim is a topical testosterone gel indicated for testosterone replacement therapy in adult males with primary hypogonadism (congenital or acquired) or hypogonadotropic hypogonadism (congenital or acquired) who have conditions associated with a deficiency or absence of endogenous testosterone. The labeling describes that Testim delivers a measured testosterone dose transdermally when applied once daily to the shoulders or upper arms, raising serum testosterone concentrations toward target physiologic ranges. Per the labeling, adverse effects may include local skin irritation, increased hematocrit, sleep apnea, changes in serum lipids, and risk of secondary exposure to others through skin contact; regular laboratory and clinical monitoring is specified. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing. Commercially available Testim is a separately regulated product, and clinical decisions regarding therapy belong with the prescribing clinician.
Depo-Testosterone
According to the FDA-approved prescribing information for Depo-Testosterone, Depo-Testosterone (testosterone cypionate injection) is a long-acting intramuscular testosterone preparation indicated for testosterone replacement therapy in males with conditions associated with a deficiency or absence of endogenous testosterone, including primary hypogonadism and hypogonadotropic hypogonadism. The labeling describes that intramuscular injections provide sustained elevation of serum testosterone concentrations, typically administered every one to four weeks depending on the prescribed dose and clinical response. Per the labeling, adverse effects may include erythrocytosis, cardiovascular events, edema, changes in libido, sleep apnea, and suppression of spermatogenesis; the labeling specifies requirements for monitoring of serum testosterone, hematocrit, and prostate parameters. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing. Commercially available Depo-Testosterone is a separately regulated product, and clinical decisions regarding therapy belong with the prescribing clinician.
Androderm
According to the FDA-approved prescribing information for Androderm, Androderm is a transdermal testosterone patch indicated for testosterone replacement therapy in adult males with primary hypogonadism (congenital or acquired) or hypogonadotropic hypogonadism (congenital or acquired). The labeling describes that Androderm delivers testosterone through daily application to clean, dry skin, providing more consistent serum testosterone concentrations compared to intramuscular injection schedules by reducing peak-and-trough variation. Per the labeling, adverse effects may include application site reactions, increased hematocrit, cardiovascular effects, prostate changes, sleep apnea, and effects on fertility; dose individualization and regular follow-up with laboratory monitoring are specified requirements. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing. Commercially available Androderm is a separately regulated product, and clinical decisions regarding therapy belong with the prescribing clinician.
Contact Us for a Personalized Care Plan
Have questions about compounding? Contact Voshell's Pharmacy — we prepare patient-specific medications pursuant to valid prescriptions from your licensed prescriber.
Medications Made Just for You
Voshell's Pharmacy Medications
Explore Voshells Pharmacy medications, including uses, availability, and trusted guidance to help you manage your health safely and effectively.
